Beacon Pharmaceuticals PLC (DSE: BEACONPHAR)

Beacon Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 13, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Market Capitalization	30,677	56,595	59,667	28,552	14,022	4,643
Market Cap Growth	-45.35%	-5.15%	108.98%	103.62%	201.99%	12.92%
Enterprise Value	37,515	62,791	63,025	30,523	15,593	6,005
Last Close Price	132.80	239.22	250.69	119.19	58.03	18.88
PE Ratio	-	108.39	61.93	31.90	35.21	37.05
PS Ratio	-	6.65	7.44	4.01	2.51	1.00
PB Ratio	4.76	9.52	10.04	5.33	3.03	1.56
P/TBV Ratio	4.81	9.52	10.04	5.33	3.03	1.56
P/OCF Ratio	-	91.11	55.14	145.26	48.16	21.06
EV/Sales Ratio	-	7.38	7.86	4.29	2.79	1.29
EV/EBITDA Ratio	-	42.24	30.64	17.47	18.46	6.96
EV/EBIT Ratio	-	64.89	38.97	22.41	46.76	19.10
Debt / Equity Ratio	1.58	1.25	0.64	0.47	0.47	0.60
Debt / EBITDA Ratio	-	5.01	1.86	1.43	2.58	2.07
Asset Turnover	-	0.67	0.83	0.91	0.93	0.95
Inventory Turnover	-	2.14	2.40	2.99	2.67	2.34
Quick Ratio	0.68	0.34	0.54	0.82	0.90	0.76
Current Ratio	1.44	1.15	1.38	1.87	1.84	2.03
Return on Equity (ROE)	-	8.58%	16.55%	17.29%	10.01%	3.94%
Return on Assets (ROA)	-	4.75%	10.45%	10.83%	3.46%	4.02%
Return on Capital (ROIC)	-	5.22%	11.47%	11.61%	3.60%	4.12%
Earnings Yield	0.90%	1.57%	3.02%	2.72%	2.53%
FCF Yield	-2.11%	-1.07%	-0.41%	-0.16%	-0.50%
Dividend Yield	1.51%	0.67%	0.64%	1.26%	-	2.65%
Payout Ratio	0.00%	72.78%	39.95%	6.88%	15.23%	100.30%
Total Shareholder Return	1.51%	0.67%	0.64%	1.26%	-	2.65%

Source: S&P Capital IQ. Standard template. Financial Sources.